Yasuhiro Sugamata

Title: Yasuhiro Sugamata: Innovator in Inflammatory Cytokine Research

Introduction

Yasuhiro Sugamata is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of medical research, particularly in understanding inflammatory cytokines. With a total of 2 patents, his work focuses on innovative methods for screening compounds that inhibit signal transduction through these cytokines.

Latest Patents

Sugamata's latest patents include groundbreaking methods for screening compounds that inhibit signal transduction through inflammatory cytokines. One of his notable inventions details the actions of inflammatory cytokines and the production of cytokines such as IL-1 and TNF, which are induced by inflammatory stimuli. His research reveals that the production of other inflammatory cytokines, such as IL-6, can be suppressed by inhibiting signal transduction through TAK1. Another patent outlines a method for screening compounds that inhibit this signal transduction, involving a sample containing TAK1 and TAB1, where binding is detected and analyzed.

Career Highlights

Yasuhiro Sugamata is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work has been instrumental in advancing the understanding of inflammatory processes and developing potential therapeutic strategies.

Collaborations

Sugamata has collaborated with notable colleagues, including Masayuki Tsuchiya and Toshihiko Ohtomo, to further enhance the research and development of innovative solutions in the field of inflammatory cytokines.

Conclusion

Yasuhiro Sugamata's contributions to the field of inflammatory cytokine research are significant and impactful. His innovative methods and collaborations continue to pave the way for advancements in medical science.